High-risk pregnancy tumor study: features and outcomes
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at patients with a high-risk pregnancy-related tumor called gestational trophoblastic neoplasia. It aims to understand their disease features, treatment outcomes, and factors that affect recovery. If you qualify, your medical information may help improve care for others like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with high-risk gestational trophoblastic neoplasia (a pregnancy-related tumor).
- Your treatment records are complete and available for review.
- You were treated at Assiut University Women's Health Hospital between January 2020 and December 2025.
- You do not have another type of cancer that could affect the results.
- You were not pregnant at the time of diagnosis.
- You do not have severe heart, liver, or kidney disease that is not related to this condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether avelumab (an immune therapy) combined with methotrexate (chemotherapy) can work well as the first treatment for low-risk gestational trophoblastic neoplasia. It aims to improve control of the tumor while keeping side effects acceptable.
This trial is creating a database for women diagnosed with gestational trophoblastic neoplasia (GTN), which includes tumors that can develop after a molar pregnancy or other pregnancy-related conditions. By joining, you help researchers better understand and improve treatment for these rare tumors.
This trial tests a combination of an immunotherapy drug (toripalimab) and a chemotherapy drug (actinomycin-D) as the first treatment for gestational trophoblastic neoplasia (GTN) with a FIGO score of 5-6. It may help patients whose disease is at a moderate risk level.
This study is for people who have a pregnancy-related tumor called gestational trophoblastic disease. It looks at this condition in patients who were diagnosed by blood test (hCG) changes or tissue testing, to better understand and manage the disease.
This trial tests whether using a hysteroscope (a tiny camera) to gently scrape the uterus again, instead of starting chemotherapy right away, can effectively treat a low-risk, pregnancy-related tumor that returns after a molar pregnancy. It's for Chinese women whose disease is still in an early, low-risk stage.
This Phase 2 trial studies whether combining camrelizumab (an immune medicine) with apatinib (a medicine that blocks blood-vessel growth) can improve treatment for women with high-risk gestational trophoblastic neoplasia (GTN) that is very high-risk, or has returned or resisted chemotherapy. It may help shrink the tumor and reduce the chance it comes back by using two different approaches together.
Hear when a new Gestational Trophoblastic Neoplasias (GTN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.